Skip to main content
Premium Trial:

Request an Annual Quote

Rancho Biosciences Joins TranSMART Foundation

Premium

NEW YORK (GenomeWeb) – Rancho Biosciences said this week that it has become an affiliate member of the TranSMART Foundation, a non-profit organization that provides an open-source platform for scientists to share pre-competitive research data.

Recently, Rancho donated 11 manually curated datasets from the Gene Expression Omnibus for cancer, immunology, and asthma to the foundation to be used for testing and hackathons. The company also hosts a version of the TranSMART platform and allows researchers to test drive the system before deciding to adopt it internally.

This week the company said that it will work with the foundation to develop a new track named "Testathon" that will provide additional testing content and serve as a forum for reporting bugs to the development team ahead of the official platform launch.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.